Some customers allege that Henry Meds failed to accurately disclose the FDA approval status of its compounded GLP-1 products before purchase. When purchasing compounded semaglutide, compounded tirzepatide, or compounded liraglutide from Henry Meds, some customers claim the marketing materials misrepresented these products as FDA-approved or equivalent to brand-name medications like Ozempic, Wegovy, Mounjaro, Zepbound, or Saxenda. The claims allege this was misleading and deceptive under consumer protection laws.
If you believe you qualify, complete the form to learn whether you may be eligible to pursue a claim.
- Age Requirement: You are 18 years or older.
- Henry Meds customer: You purchased a compounded GLP-1 weight loss product (compounded semaglutide, compounded tirzepatide, or compounded liraglutide) from Henry Meds on or after May 2023.
If you believe you have been impacted, here’s what you can do:
- Gather Your Information: Collect receipts, email confirmations, app-store purchase history, screenshots of your Henry Meds account, or bank records showing your purchases of compounded GLP-1 products.
- Prepare Your Account Details: Have ready the email address you used for your Henry Meds account, the state where you resided when taking the medication, and the payment method(s) you used (credit/debit card, PayPal, or other third-party payment method).
- Complete the Form: If you believe you qualify, complete the form and submit your information and documentation to learn if you may qualify to pursue compensation through arbitration.